The KKR acquisition of Biosynth Carbosynth, an innovative life sciences reagents, custom synthesis and manufacturing services company, has closed. Included in the deal is Biosynth Carbosynth’s acquisition of vivitide, a…
The KKR acquisition of Biosynth Carbosynth, an innovative life sciences reagents, custom synthesis and manufacturing services company, has closed. Included in the deal is Biosynth Carbosynth’s acquisition of vivitide, a…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


